Natural History of Shoulder Pathology in Manual Wheelchair Users

Overview

About this study

The objective of this application is to continue tracking the progression of rotator cuff pathology after SCI while deepening our understanding of contributing factors to tendon damage.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Group 1:

  • 18 – 70 years of age at the time of consent.
  • Use of a manual wheelchair as the primary mode of mobility.
  • Functional upper extremity range of motion.
  • Willingness to participate in study.
  • Ability to return to receive shoulder MRI 1-3 times/year, and once per year receive physical exam.

Group 2

  • 18-70 years of age at time of consent.
  • Able to walk independently with no reliance on an orthotic, prosthetic, or gait aid.
  • Functional upper extremity range of motion.
  • Willingness to participate in study.
  • Ability to receive shoulder MRI 1-3 times/year, and once per year receive physical exam.

Exclusion Criteria:

Group 1

  • Previous diagnosis of bilateral complete supraspinatus tendon tears prior to spinal cord injury or suspected complete bilateral supraspinatus tendon tears with physical exam.
  • They have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Group 2

  • Any documented musculoskeletal or neurological disorders that would be expected to impact shoulder health or change ability to walk independently.
  • Previous diagnosis of unilateral or bilateral complete supraspinatus tendon tear(s) prior to enrollment or suspected complete. supraspinatus tendon tear with physical exam
  • They have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence.

Eligibility last updated 8/13/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Melissa Morrow, Ph.D.

Closed for enrollment

Contact information:

Meegan Van Straaten P.T.

(507) 255-7216

VanStraaten.Meegan@mayo.edu

Mankato, Minn.

Mayo Clinic principal investigator

Melissa Morrow, Ph.D.

Closed for enrollment

Contact information:

Sarah Gifford CCRP

(507) 422-5848

Gifford.Sarah@mayo.edu

Minneapolis, Minn.

Mayo Clinic principal investigator

Melissa Morrow, Ph.D.

Closed for enrollment

Contact information:

Sarah Gifford CCRP

(507) 422-5848

Gifford.Sarah@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20167665

Mayo Clinic Footer